Marissa Milchak, MD
Dermatology · Philadelphia, PANPI 1942664628
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,504 of the $1,679 with a category attached, or 89.6%. AbbVie accounts for 61.1% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $790 and has fallen 93.7% since, to $50 in 2025. That places this record below the midpoint for dermatology clinicians in PA, where the typical reported total is $1,724.
Across 52 payments — averaging $32.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$214
- Eli Lilly$175
- Journey Medical Corporation$140
- Mayne Pharma Commercial LLC$54
- Regeneron Healthcare Solutions, Inc.$28
- plus $43 from 3 others
What the payments were for
- Consulting fees$17510%
- Food & beverage$1,50490%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 35 | $1,025 |
| Johnson & Johnson | 2 | $214 |
| Eli Lilly | 1 | $175 |
| Journey Medical Corporation | 2 | $140 |
| Mayne Pharma Commercial LLC | 7 | $54 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Amgen | 1 | $24 |
| Dermavant Sciences, Inc. | 1 | $14 |
| Organon | 2 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,679 in reported general payments places this provider in the 45th percentile of 626 dermatology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 15 | $801 |
| Tretinoin | 13 | $591 |
| Ketoconazole | 12 | $410 |
| Minoxidil | 19 | $228 |
| Triamcinolone Acetonide | 20 | $130 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Philadelphia
- Stephen HessPhiladelphia$1.7M
- Joel GelfandPhiladelphia$649K
- Victoria WerthPhiladelphia$547K
- Nicholas MollanazarPhiladelphia$369K
- Harold FarberPhiladelphia$284K
- Jules LipoffPhiladelphia$259K
- Susan TaylorPhiladelphia$207K
- Joy WanPhiladelphia$176K
- Harold MilsteinPhiladelphia$120K
- David MargolisPhiladelphia$118K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.